News Agency
The Times

Belief BioMed Successfully Completed Dosing of First Subject in the Registrational Clinical Trial for Hemophilia A

  • Written by PR Newswire

SHANGHAI, Jan. 3, 2024 /PRNewswire/ -- Belief BioMed Group (BBM), an industry-leading biotech company focusing on innovative gene therapies, announced the completion of first subject dosing in its registrational clinical trial (CTR20233400) of BBM-H803, a gene therapy for hemophilia A, independently developed and produced by Belief BioMed.

BBM-H803...

Read more: Belief BioMed Successfully Completed Dosing of First Subject in the Registrational Clinical Trial...

Commercial Leasing Mistakes That Can Cost Your Business

Signing a commercial lease is a significant commitment, and the mistakes made at the outset of a tenancy can follow a business for the entire duration of the agreement. Many tenants enter lease negotiations without a full understanding of what... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion